Wednesday, 11th November Clinical Oncology Society of Australia Annual Scientific Meeting 2026

• Exploring the biomarker era, mechanisms of drug resistance, and the evolving landscape of precision oncology - Herbert Loong
• Optimising prescribing: Which adults with solid tumours benefit most from multi-gene pharmacogenomic panel testing? - Jessica Keen
• Thriving in The Long Middle - Beth Ivimey

This session includes a 15-minute panel discussion and will be joined by Dr Tara Horrill. 

• Radiotherapy for Older patients  - Penny Mackenzie
• Frailty in Cancer: Moving from Identification to Intervention by Optimising Physical Function Across the Cancer Continuum - Germaine A Tan
• Fuelling Resilience: Nutrition's Role in Frailty - Elise Treleaven
• More than just age: Understanding frailty in people with cancer   - Elspeth Horwitz

This session includes a 30-minute panel discussion. 

This session includes a 10-minute introduction by Vivienne Milch. 

• You’re Not Too Young: Rethinking Early Detection in a Generation That Thinks It Has Time   - Hugo Toovey
• Identifying the aetiological drivers of early-onset colorectal cancer through the mapping of mutational processes - Daniel D Buchanan
• Diagnostic routes, intervals to treatment and perceived delays in diagnosis for early-onset vs older-onset colorectal cancer. - Rebecca J Bergin
• Bridging geography: a national virtual multidisciplinary team model for early-onset colorectal cancer - Prasad Cooray
• 15 years of Bowel Cancer Australia Specialist Support Services - Caring for People with Early-Onset Colorectal Cancer. - Fiona F Radford
• Pregnancy-associated cancer: an unexpected and devastating intersection - Sophie Boffa

• Smoke, vapes and mirrors: New initiatives prompted by looking back - Freddy Sitas
• Vaping while smoking: the worst scenario - Becky Freeman
• Interventions and campaigns: is there an end? - Anita Dessaix

This session includes a 30-minute panel discussion and will be joined by Malinda Itchins and Cassandra Mazza. 

• Anticipatory anxiety in cancer screening: determining motivators and barriers - Tara Clinton-McHarg
• Cancer screening: How communication of breast cancer risk can affect women's anxiousness - Brooke Nickel
• Genetics: Anxiety and Inherited Disease Risk - Communicating about genetic risk - Rachel Williams
• In it together: Communication of fears and worries between survivors and their families   - Kyra Webb
• Precision Medicine, Persistent Uncertainty: Navigating Fear in Modern Cancer Care - Jia (Jenny) Liu

This session features a 30-minute panel discussion. 

• WORKING TOGETHER WITH PEOPLE WITH INTELLECTUAL DISABILITY TO ADVANCE EQUITABLE CERVICAL CANCER ELIMINATION: FINDINGS FROM THE SCREENEQUAL CLINICAL TRIAL - Deborah Bateson AM
• CanACTIVATE: Co-designing a national workforce development program to support the inclusion of exercise within cancer care. - Kate A Bolam
• The silent impact: educational and career disruptions among AYA with a parent or sibling facing cancer - Jennifer Cohen
• How does COSA’s ‘Roadmap to Reducing Financial Toxicity Experienced by People Affected by Cancer’ align with the Australian Cancer Plan? An expert-informed document analysis - Reegan Knowles
• A qualitative exploration of the perspectives and barriers to cancer clinical trial participation among Chinese speaking Australians - Alexander Li
• Evaluation of an online training module to address fear of cancer recurrence in clinical practice - Ben Smith

• Supplements in Cancer Care: Separating Signal from Noise - Judith Lacey
• Building AI Health Literacy for the AI-health transformation: supporting safe, inclusive and equitable health outcomes - Kirsten McCaffery
• Nutrition Conversations in Cancer Care: Navigating Complexity, Evidence, and Patient Perspectives - Elizabeth Isenring
• The Gut Microbiome and Cancer Outcomes: Hype or Hope? - Craig Haifer

This session includes a 25-minute panel discussion and will be joined by Michael Ellies. 

• Age standardised incidence rate, risk factors, and outcomes of pregnancy associated cancer: a Queensland population data linkage study - Muyun (Sarah) Cao
• Real-world healthcare utilisation and costs in a lung cancer screening cohort: evidence from the Australian arm of the International Lung Screening Trial - David Goldsbury
• Ovarian cancer prognosis in women with a history of endometriosis: differences by endometriosis subtype - Amandi Hiyare Hewage
• The future burden of kidney cancer in Australian men and women preventable by modifying current behavioural risk factors: An international meta-analysis - Maarit A Laaksonen
• Long-term projections of cancer prevalence in Australia to 2050: a population-based statistical modelling study - Qingwei Luo
• Trends in early-onset cancer incidence in Australia - Carolyn Nickson
• Ethnic and geographic variations in prostate cancer testing and incidence in New South Wales: A Population-based cohort study - MD Mijanur Dr Rahman
• Lifestyle factors across generations and early-onset breast cancer risk: Evidence from the Australian Longitudinal Study on Women’s Health - Md Sohel Rana
• Variations in cancer incidence and stage by refugee status in New South Wales. - Siphiwe Ratladi
• The health economic case for expansion of liver cancer screening and surveillance in Australia - Joachim Worthington

• Understanding patient experiences: Perceptions and Recall of Patients referred for Prostate Cancer treatment - Ella Cleary
• Inside the Trial: Patient experiences of innovation in minimally invasive thoracic surgery for lung cancer - Jennifer Donnelly
• Investigating effects of neuropsychological feedback on self-reported cognitive impairment in cancer survivors: A pilot randomised controlled trial - Heather J Green
• Mapping patient-reported measures to Australia’s Pan Cancer Core Outcome Set: recommendations for national alignment - Sandra Nolte
• The burden of menopausal vasomotor symptoms: results from a national survey of 2,000 Australian cancer survivors - Michelle Peate
• Changes in perceived cognitive functioning following a codesigned online group cognitive rehabilitation for prostate cancer survivors on androgen deprivation therapy: Series of single-case experimental designs - Lorna Pembroke
• Getting to the core of the matter: establishing Australia’s core outcome set for patient-reported measures in cancer - Imogen Ramsey
• "Someone Was Looking Out for Me": Patient Perspectives on What Makes Multimodal Prehabilitation Work - Kristy-Lee Raso
• Psychological Distress During Radiotherapy: Examining Trajectories and Predictors using a National Routine Screening Dataset of over 31,000 patients - Chindhu Shunmuga Sundaram
• Geographic variation in symptoms at palliative care admission among Australian cancer patients - Jared Tang

• Prehabilitation in cancer care: an evidence update and implications for practice - Matthew P Wallen
• What Matters Most: Consumer‑Clinician Priorities in Prehabilitation - Christina Prickett
• Prehabilitation in Practice: Barriers, Enablers, and Real-World Implementation - Kristy-Lee Raso
• Value-based prehabilitation models of care - Haitham Tuffaha
• Embedding Prehab: What We've Learned & Where We're Heading - Daniel Steffens

This session includes a panel discussion. 

• Making sense: how to ensure clarity and understanding when explaining pharmacogenomic information to patients? - Jessica Keen
• Documentation of infusion-related reactions to systemic anti-cancer therapy: Development of a COSA Position Statement - Jessica Donnelly
• Personalised Dosing of Cancer Medicines in Clinical Practice - Ganessan Kichenadasse
• Postcode Shouldn’t Decide Care: Access to Cancer Medicines in Rural Australia - Katie Foy

• Breast density and its impact on screening - Carolyn Nickson
• Screening and the elimination of cervical cancer in Australia - Megan Smith
• Making lung cancer screening a reality: the essential role of Primary Care - Vivienne Milch
• Psychological impact of cancer screening  - Rachael H Dodd

This session includes a 10-minute panel discussion. 

• 10 year survival outcomes following early feeding via a prophylactic gastrostomy – a randomised controlled trial in patients with head and neck cancer - Teresa Brown
• Mental Health Constructs and Tools in Exercise Oncology: A Systematic Review and Meta-Analysis - Jamie Chong
• Phase 2 trial of the PD-1/VEGF bispecific antibody, PF-08634404 (SSGJ-707), plus chemotherapy (chemo) in advanced NSCLC: updated results  - Malinda Itchins
• Self-reported cognitive and educational impacts among survivors of child, adolescent and young adult cancer - Ursula M Sansom-Daly
• Quality of life and fitness outcomes from the CCTG CO.21/CHALLENGE trial: structured exercise after adjuvant chemotherapy for colon cancer - Janette L Vardy
• Pretreatment Cardio-Oncology Risk Score (PCORS): Development and Internal Validation in Treatment-Naïve Breast Cancer   - Zechang Dr. Xin

• Rurality as an independent driver of cancer mortality: a systematic review and meta-analysis with implications for Australian cancer equity - Skye Marshall
• Variations in cancer incidence and stage by migration status in New South Wales. - Siphiwe Ratladi
• From Opportunistic Testing to Initiated Discussion: Developing Australia's 2026 Guidelines for the Early Detection of Prostate Cancer - David P Smith
• Polygenic risk scores enhance prostate cancer risk stratification: development and external validation of 5-year risk prediction models in UK and Australian cohorts - Julia Steinberg
• The Change in Profile and Systemic Therapy Exposure of Cancer Survivors in New South Wales (2005-2019): A Population-Based Study - Monica Tang
• Burden of reconstructive surgery for head and neck cancer: impact on health utility, quality of life, function, and work productivity - Rebecca L Venchiarutti

• Development and Characterisation of Iron Oxide Nanoparticles and a Three-Dimensional Glioblastoma Spheroid Model for Preclinical Chemoradiotherapy Research - Fatemeh Abhari
• MAD beyond tumour grade: baseline radiomics predicts survival in advanced GEP-NENs undergoing PRRT - Jonathan Ben Daniel
• A Place-Based Network Model to Strengthen Regional Cancer Research Capacity and Translation - Nikola Bowden
• A Multimodal Approach to Early Detection of Postpartum Breast Cancer Using Breast Milk: Mouse Models, Organoids, and Human Samples - Muyun (Sarah) Cao
• The LAMp-LC Study: Unveiling the lung microbiome in Australians with early- and late-stage lung cancer - Bryan A Chan
• Return-to-Work for Cancer Survivors in the Australian Life Insurance Context: A Multi-Stakeholder Qualitative Study - Xi Wen (Carys) Chan
• The future of radiomics in NENs: prognostication, treatment selection and AI - Jacky Wei-Ting Chen
• MT2 Enhances Paclitaxel-Mediated Antitumor Efficacy Across Distinct Cancer Models - KM CHENG
• Dietary whey hydrolysate and medium-chain triglycerides contribution to optimising methotrexate treatment outcomes in Dark Agouti mammary adenocarcinoma - Ifeoma Dikeocha
• The contribution of nurses to palliative care clinical research investigator teams: A qualitative study  - Belinda Fazekas
• Selectivity and Pharmacokinetic Optimization of 7-Aminoquinazolines as Potent CSF1R Kinase Inhibitors for Human Triple-negative Breast Cancer Treatment - Hsing-Pang Hsieh
• “When you know better, you do better.” A Qualitative Exploration of Facilitators and Barriers of Adherence Among Breast Cancer Survivors Participating in a Telehealth Lifestyle Intervention - Shaun Kirsten
• Tumor Collagen-targeted T-cell therapy for sarcoma: The source of tumor collagen, mechanism of reduction, preclinical study, and early peek of clinical trial result - Shulin Li
• Ionizable Lipids Discovery Enable Functional mRNA Delivery for Clinical Translation of mRNA Vaccines - Wen-Shan Li
• How cancer-related fear influences bowel cancer screening attitudes and intention to screen - Philippa M Maynard
• So where do we start? Developing age-appropriate clinical practice guidelines that reflect areas of greatest clinical uncertainty and maximise potential health impacts in an era of rising rates of bowel cancer in young people - Tanya N Millard
• Complications in Needle Prostate Biopsy: A Systematic Literature Review  - William Moore
• The long-term effect and burden of late radiation brain injury and radiation-induced brain necrosis. - Kathleen Rolfe
• A window into the unknown: novel mass spectrometry methods to profile tumour effusion proteomes for cytokine detection and chemotherapy response prediction - Jack Scanlan
• Development and implementation of patient-reported outcome measures online training in Western Sydney Local Health District Cancer Services - Chindhu Shunmuga Sundaram
• Analysing the cytotoxic effects of plant-derived compounds from wasabi and liquorice root and their interactions with docetaxel on prostate cancer cells. - Samuel SS Sii
• Biomarker landscape in gastro-entero-pancreatic neuroendocrine tumours: from chromogranin A to multi-omic panels - Sachpreet Singh Singh
• Repurposing drugs and natural compounds to enhance the cytotoxic efficacy of doxorubicin on breast cancer cells. - Montana Vassallo
• Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review and a Meta-analysis - Yufan Wang
• EpCAM Drives TNF-α-Induced Anaplastic Thyroid Cancer Progression Through Activation of the ERK-EGR1 Signaling Axis - Han-Chung Wu
• Comparable Local Control but Model-Dependent Abscopal Responses After FLASH and Conventional Radiotherapy in Tumors With Contrasting Immunogenicity - Tosol Yu
• Intratumoral Methylobacterium promotes papillary thyroid carcinoma cell  progression via BCAT2-dependent activation of the PI3K/Akt/mTOR signaling pathway. - Qin Zheng
• Total body photography for the diagnosis of cutaneous melanoma in adults: updated systematic review and meta-analysis    - Shannon Baker
• Co-designing a reduced-dose digital mental health intervention with, and for, people with cancer: Finding My Way – Micro - Liberty A Barry
• Utilisation of intramuscular and intermuscular fat to develop a new skeletal muscle grading score which can predict treatment outcomes for locally advanced rectal cancer. - Alex Besson
• Body composition changes during neoadjuvant treatment for locally advanced rectal cancer predicts pathological tumour response. - Alex Besson
• Impact of body mass index on Clinicopathological profile in breast cancer: Tunisian cohort study - Mohamed Bourhil
• Real‑world effectiveness of neoadjuvant pembrolizumab in triple‑negative breast cancer: a retrospective case series from the Salah Azaïez Institute, Tunisia - Mohamed Bourhil
• Does tumour budding predict prognosis in patients with gasto-oesophageal adenocarcinoma? A systematic review and meta-analysis - Dominic Bullock
• Impact of proton pump inhibitors on survival outcomes and immune-related adverse events in patients receiving immunotherapy: a single centre experience - Ji-In Chung
• Nutrition Impact Symptoms and Nutrition Outcomes in Patients with Pancreatic and Hepatobiliary Cancers During and After Treatment: A Systematic Review and Meta-Analysis. - Kate Connell
• Sustained remission and long-term survival outcomes with dostarlimab plus chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial (Encore) - Melissa MJ Farnham
• A review of five-year outcomes using Oncotype-DX guided adjuvant treatment in HR-positive early breast cancer – single site experience. - Lachlan Fitzpatrick
• Real-World Outcomes of First-Line Systemic Therapy for Metastatic Renal Cell Carcinoma Across Northern Sydney: A Multicentre Retrospective Cohort Study - Vaishnavi Anu Ganapathy
• Fungating testicular germ cell tumours: Case report and narrative review of clinical presentation and management strategies   - Daniel S GARCIA
• Nutritional supplements and medicinal mushrooms in cancer care: making sense of the clinical trial evidence from three linked syntheses - Suzanne Grant
• Multimodality treatment of EBV-positive oligometastatic nasopharyngeal carcinoma with maintenance toripalimab: a real-world case study - Thomas Hansen
• First-line PF-08634404 (SSGJ-707), a PD-1/VEGF bispecific antibody, + chemotherapy for advanced/recurrent endometrial cancer (EC) - Michelle Harrison
• Advancing Equity in Clinical Trials: Integrating a Sponsor-Initiated Decentralised Methodology Statement into Protocols - Francis Hinds
• Clinical Symbiosis: Treating Patient Centricity and Study Success as Co-Primary Priorities in Oncology Research - Francis Hinds
• Virtual Delivery of Supervised Physical Fitness Assessments for Childhood Cancer Survivors: A Feasibility Study - Chrissie Ho
• PROpatient: A registry-based randomised controlled trial of symptom monitoring, using patient-reported outcome measures and centralised care coordination, to improve quality of life in patients with upper gastrointestinal cancers. - Liane J Ioannou
• Friend or foe? Impact of concomitant medications on survival outcomes in patients receiving immune checkpoint inhibitors   - Maia Ismail
• Oral paclitaxel(DHP107) versus intravenous weekly paclitaxel in HER2-negative recurrent or metastatic breast cancer:a single-center exploratory analysis of the OPTIMAL phase III study - Lei Jiang
• Factors influencing use of magnetic resonance imaging in newly diagnosed advanced lung cancer patients: A single centre retrospective review - Tianjian Jiang
• Perineural invasion in gastroesophageal cancer: impact on clinical outcomes - Raphel RJ Jomaah
• Differentiating functional and sleep-related factors of reduced health utility after head and neck free-flap reconstruction - Frances Kan
• Reduction in costs with a 4-week course of moderately hypofractionation chemoradiation in unresectable stage 3 non-small cell lung cancer: a secondary analysis from the phase 2 MODERN-LUNG trial - Mahesh Kumar
• Impact of Medicare Funding on Dihydropyrimidine Dehydrogenase Testing in Oncology Practice - Neil Kim Chiu Lam
• Rethinking lymphoedema prophylaxis after groin dissection for melanoma - Teresa S Lee
• A prospective study investigating the utility of sentinel lymph node biopsy (SLNB) in early-stage node-negative (cT1N0) Merkel Cell Carcinoma (BIOPSY-ME) - Ryan W Lim
• Diagnostic Challenges in Immune Checkpoint Inhibitor-Mediated Triple M Syndrome: A case highlighting diagnostic uncertainty.  - Jonathan Loh
• Clinical effectiveness of low fixed-dose rasburicase for prophylaxis and treatment of tumour lysis syndrome in patients with haematologic malignancies  - Taylor Mackie
• Gene expression profiling of perineural invasion in gastroesophageal cancers - Madeline MacLean
• Exploring Background Factors and Diagnostic Pathways in Colorectal Cancer   - Meghana Maddula
• Pay It Forward: Carers' perspectives of a novel peer to peer support initiative for individuals receiving treatment for head and neck cancer. - Matthew Mason
• Exploring longitudinal changes in and relationships between nutrition impact symptoms, muscle mass and malnutrition following oesophagogastric cancer surgery. - Lisa Murnane
• CDK4/6 inhibitors plus Fulvestrant in hormone receptor-positive, HER2-negative Advanced Breast Cancer: A pilot retrospective study  - Trung Nguyen
• Osimertinib in Advanced Non-Small Cell Lung Cancer with Uncommon or Compound EGFR Mutations: A retrospective study  - Trung Nguyen
• Objective response to fecal microbiota transplantation plus immune checkpoint inhibition differs by prior immune checkpoint inhibitor exposure: A meta-analysis. - Shreya Parmar
• Systemic Therapy After Trabectedin in Advanced L-Sarcomas: Treatment Patterns and Outcomes From the Multicentre SEPSaC-01 Cohort - Agnieszka Pietruszka
• Complete responses to first-line pembrolizumab plus chemotherapy in PD-L1-positive advanced triple-negative breast cancer: a CEBCC-101 analysis - Agnieszka Pietruszka
• Immune-related Adverse Events in Neoadjuvant Triple Negative Breast Cancer Treatment: A single centre, retrospective cohort - Benjamin Rao
• Patient selection for primary cytoreduction or neoadjuvant chemotherapy in the treatment of ovarian cancer over time - Tanya Ross
• Exploring The Fidelity of Resistance Training Interventions in Regional, Rural, And Remote Cancer Care: A Systematic Scoping Review - Christopher Rowe
• Delivering Resistance Training to People with Cancer in Regional, Rural, and Remote Australia: A Qualitative Study of Exercise Professional’s Perspectives - Christopher Rowe
• Successful treatment of refractory Immune Thrombocytopenia with a combination of amifostine, rituximab and romiplostim: A case report  - Marissa Ryan
• Real-World EGFR Tyrosine Kinase Inhibitor Outcomes in Advanced NSCLC: A Single-Centre Audit With Focus on Elderly Patients - Ahmed Shouman
• Reverse cardio-oncology in hematologic malignancies: hypoxic, inflammatory, and clonal pathways linking cardiovascular disease and cancer - Sachpreet Singh Singh
• Healthcare navigation burden and patient delay drive advanced-stage head and neck cancer presentation in northern india - Sachpreet Singh Singh
• Long‑term overall survival follow-up of toripalimab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma - Paul Smart
• Does exercise improve survival after a cancer diagnosis? A living systematic review and meta-analysis of randomised controlled trials - Rosa R Spence
• Management of oligometastatic cervical cancer: a review of the literature to inform clinical practice guideline development - Dana Stefanovic
• Incidence, Extent, and Management of Hypomagnesemia in Colorectal Cancer Patients During Epidermal Growth Factor Receptor Inhibitor (EGFRI) and Fluorouracil (5FU) Based Therapy at Ipswich Hospital: A Retrospective Audit - Guru Sule
• Fear of cancer recurrence in people attending the Sydney Cancer Survivorship Centre clinic (SCSC) - Sim Yee (Cindy) Tan
• A retrospective analysis of Selective InternalRadiation Therapy (SIRT) and chemotherapyfor metastatic pancreatic adenocarcinoma - Sue ST Thang
• Incidence and clinicopathological characteristics of very young onset, young onset and late onset colorectal cancer in a culturally and linguistically diverse Sydney population - Alexandra Thoms
• Malnutrition risk is independently associated with hospitalisation in early-phase oncology trial participants: a retrospective cohort study - Stephanie Vassallo
• Population-level impact of the COVID-19 pandemic on radiotherapy utilisation and fractionation for breast and lung cancer in NSW - Shalini K Vinod
• Does timing matter? A retrospective review of immune checkpoint inhibitor administration and cancer treatment response - Madeleine Washbourne
• Incidence of febrile neutropenia and time to count recovery in AML patients receiving pegylated G-CSF following HiDAC consolidation - Michael Whordley
• Association between dietary patterns and cardiometabolic health markers in overweight or obese men treated with androgen deprivation therapy: a cross-sectional analysis of the TelEX trial - Hattie H Wright
• Preliminary efficacy of the ‘RecoverEsupport Breast’ digital health intervention to enhance recovery in women undergoing surgery for breast cancer - Rebecca Wyse
• CIFeR Advanced - Adapting a clinician led intervention to address fear of cancer progression across advanced malignancies - Howard Yu
• Clinicopathological study of cervical lymph node metastasis in patients with oral tongue squamous cell carcinoma with pT1-2 - JIE YU
• Clinicopathological study of cervical lymph node metastasis in patients with oral tongue squamous cell carcinoma with pT1-2 - JIE YU
• Association between C-reactive protein-albumin-lymphocyte index and overall survival in surgery patients with oral squamous cell carcinoma - JIE YU
• Outcome prediction model impact on clinician confidence and treatment recommendations in older patients with head and neck cancer treated with radiotherapy - Farhannah Aly
• Developing a large-scale population microsimulation model to evaluate the benefits, harms, and economic effects of risk-stratified melanoma screening in Australia - Louisa Collins
• Personalized Drug Prioritization in Glioblastoma Through Pathway-Level Transcriptomic Network Analysis  - Tolga Corbaci
• The power of early checks: Understanding diagnosis in cervical and colorectal cancer - Victoria Donoghue
• Precision requires visibility: Building the data foundation for equitable metastatic breast cancer care - Vicki Durston
• Dual-Strategy ctDNA MRD Assessment Improves Detection Sensitivity Across Diverse Early Breast Cancer Cohorts - Joachim Fluhrer
• Intra-tumoural manganese is associated with radioresistance and survival in glioblastoma (AO 02.25) - Gerald B Fogarty
• Cost-utility of BRCA and homologous recombination deficiency testing-guided treatments in ovarian cancer - Karitika Kashyap
• Implementing automated dashboards to drive equity in colonoscopy access and quality: a metro-regional collaboration - Diana Lewis
• Precision oncology in practice: Identifying support needs among Australian medical oncologists - Shuang Liang
• Cost-utility of UDP-glucuronosyltransferase 1A1 (UGT1A1) deficiency testing-guided irinotecan treatment in pancreatic cancer - Kayleigh Mackenzie
• TrialCatch.org - An AI assisted clinical trial matching platform for oncologists in Australia and New Zealand. - Samuel R Miller
• Towards precision supportive care: A risk-stratified model to predict and address physical decline during chemotherapy - Lisa E Parry
• Pharmacological interventions to support cancer treatment in patients with a Serious Mental Illness: Preliminary results from a scoping review  - Lachlan Roth
• A learning cancer system for precision care: integrating clinical, population and patient-reported data across NSW - Shelley Rushton
• Cancer pharmacy standards for the precision generation: Update of the Advanced Pharmacy Australia (AdPha) Oncology and Haematology Standards of Practice - Marissa Ryan
• Advancing erectile dysfunction care after prostate cancer treatments: outcomes from an international multidisciplinary consensus building workshop - Urooza Sarma
• Bridging the gap. Australian prescribing guidelines compared to international pharmacogenomic standards - Ruby Soueid
• Driving NLCSP implementation: a network strategy for health service readiness and earlier detection of lung cancer  - Wanda Stelmach
• Pre-emptive DPYD Genotyping-Guided Fluoropyrimidine Treatment in Solid Tumours: A Real-World Cost-Utility Analysis - Valerie Sutanta
• Case Report: A rare case of triple M syndrome following an immune check point inhibitor.  - Helena HV Vomvellis
• From Isotopes to Impact: Stakeholder Perspectives on the Access to Theranostic Radiopharmaceuticals - Yufan Wang
• The Role of Consumer Engagement in Improving Breast Density Policy, Practice and Research   - Amanda Winiata
• Tailoring a primary care-based cancer clinical trial for the Chinese community - Yuhang Zhang
• Early-onset, female-predominant adenoid cystic carcinoma in an Omani population: clinicopathological features and patterns of failure - Abdallah Al Alawi
•  Dyspnoea-related distress in an Australian palliative care population with lung cancer. - Jill Chen
• Patterns of PSA testing in Australian men aged 70 years and older - Karen Chiam
• Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic men: findings from the 45 and Up Study - Karen Chiam
• Self-reported cancer-related behaviours by social proximity to a recent cancer diagnosis - Daniel G Coro
• Patient characteristics and treatment patterns of patients with advanced NSCLC harboring MET exon 14 (METex14) skipping enrolled in MOMENT disease registry - Stephanie Gasking
• De novo and acquired MET amplification in patients with non-small cell lung cancer (NSCLC) treated with tepotinib: Results from a real-world data analysis in Australia - Stephanie Gasking
• Contemporary epidemiology and real-world management of hepatocellular carcinoma (HCC) in Australia: insights from a prospective Australian national clinical quality registry - Liane Ioannou
• Potential risk factors associated with early-onset cancers: rapid review - Yoon-Jung Kang
• AllClear-RWE: Real-world evidence on early breast cancer treatment and outcomes ─ Baseline characteristics of a population-based cohort study, NSW, Australia, 2005-2019     - Sol Libesman
• Projections of incidence and mortality for head and neck cancer by clinically relevant groups in Australia to 2044 - Qingwei Luo
• Secondary Primary Cancers Among Childhood Cancer Survivors: A Population-Based Study using the Australian Childhood Cancer Registry  - Louise Marquart-Wilson
• Increased Risk of Clinically Significant Prostate Cancer Among Melanoma Survivors: A Population-Based Cohort Study - Visalini Nair-Shalliker
• Allostatic load and comorbidities in people with and without cancer: an analysis of the National Health and Nutrition Examination Surveys 2015-2023 - Huah Shin Ng
• Trends in risk factor exposure in relation to trends in early-onset cancers in Australia - Carolyn Nickson
• Trends in Pre-biopsy Magnetic Resonance Imaging Uptake Across Prostate Cancer Risk Groups: Findings from the ACT Prostate Cancer Outcomes Registry (PCOR‑ACT) - MICHAEL ODUTOLA
• Sleep quality, physical activity and health-related quality of life in a population of individuals undergoing surveillance for colorectal cancer. - Ann Peter
• Association between risk-related lifestyle factors, screening adherence and breast cancer incidence: A decomposition analysis - Md Sohel Rana
• Breast cancer recurrence in contemporary population-based studies: a systematic review and meta‑analysis of local, regional, locoregional and distant outcomes - Meghan Stephensen
• Prognostic factors for prostate cancer in patients on active surveillance: a scoping review protocol - Chifeng Tan
• Impact of travel distance and time on treatment and outcomes for oral cavity cancer in NSW and ACT: a population-based data linkage study - Rebecca L Venchiarutti
• Visceral fat deposition among survivors of pediatric acute lymphoblastic leukemia - Carmen L Wilson
• 30-year trends in Gastric and Oesophageal Cancer in NSW: incidence, survival and mortality 1992-2022 - Georgette Wood Wood
• Immunotherapy for locally advanced cervical cancer: a systematic review to inform Australia’s first Cervical Cancer Management Guidelines. - Susan Yuill
• Clinical Characteristics of Pneumocystis jirovecii Infection During First-Line Chemotherapy for Solid Tumours in non-HIV patients: A retrospective case series - Mariam Zaib
• Post-treatment nutrition interventions for childhood cancer survivors - Susannah K Ayre
• The effect of dietary interventions on cancer survival: A living systematic review and meta-analysis of randomised controlled trials - Brooke P Baker
• A health economic evaluation of Finding My Way-Advanced, a self-guided digital mental health intervention for women with metastatic breast cancer. - Lisa Beatty
• Treatment experiences, preferences, and information needs among Australians living with metastatic breast cancer: results from a national survey - Frances Boyle
• “I would have felt less lost”: Evaluating the LGBTQI+ People and Cancer resource     - Jenni Bruce
• The McGrath Model of Care and the Living Well framework - Vanessa N Brunelli
• Understanding unmet supportive care needs in regional paediatric oncology: Insights from children with cancer, their parents, and multidisciplinary health and community service professionals. - Jamie Bryant
• Financial toxicity and its impact on patient and caregiver wellbeing following treatment for gastrointestinal cancers - Norma B Bulamu
• Beyond toxicity: A nurse practitioner-led immunotherapy supportive care clinic in a regional cancer centre - Danielle Burge
• Ruxolitinib for the treatment of CAR-T-related, corticosteroid-refractory ICANS: a single-centre case series  - Rachel Cathcart
• The CanHEAL Program: Advancing equity in cancer-related lymphoedema care for people from culturally and linguistically diverse backgrounds.  - Ashfaq Chauhan
• Clonidine as an Adjuvant for Opioid-Induced Hyperalgesia in Advanced Cancer Pain: A Case Report and Mechanisms. - Katarzyna Chmiel
• Hydromorphone-Induced Delirium in a Patient with Advanced Cancer: A Case Report - Katarzyna Chmiel
• Lost Opportunities, Lasting Costs: Financial impacts and future support needs of Adolescents and Young Adults impacted by Cancer - Jennifer Cohen
• Food, Movement, Sleep, and Social Patterns among People with Cancer and Their Carers in Supported Accommodation - Daniel G Coro
• Clinical trials in the home: Enhancing trial recruitment in cancer supportive and palliative care research - a feasibility trial of acupunture for cancer pain - Lucy Demediuk
• Enhancing supportive care through a telehealth nurse-led survivorship clinic - Jodi Dumbrell
• Title: Navigating the Psychosocial Journey: A Meta-Ethnographic Review of the Psychosocial Needs and Experiences of Children and Adolescents (0–19 Years) Diagnosed With Cancer Across the Care Continuum - Alyssa J Ebert
• Evaluating a new skin-care product in the prevention of radiation-induced skin reaction for patients - Vanessa Evans
• Psychotherapeutic interventions and suicide-related outcomes among adults with advanced cancer: A scoping review - maria ftanou
• Mapping survivorship care across Victoria: Findings from a statewide environmental scan to inform equitable scale-up - Frezsa Fulia
• Enabling Rapid Implementation of Survivorship Models of Care Through the VICS Survivorship Grants Program - Frezsa Fulia
• Scaling Survivorship Care Across Victoria: Early Impact of the VICS Statewide Survivorship Program - Frezsa Fulia
• Indirect calorimetry in oncology - Kate Furness
• Web-based cognitive rehabilitation for patients with aggressive lymphoma with perceived cognitive impairment: a randomised pilot study - Priscilla Gates
• Improving supportive care for children with cancer in low-resource settings: Experience and challenges from a tertiary hospital in Burundi - Jean HAKIZIMANA
• Measuring Financial Burden: Rural–Metropolitan Disparities in Breast Cancer Costs and a Novel Diagnostic Cost Methodology - Stewart Harper
• Living Loudly, Leading to the End:  Letters, lyrics  and legacy; A Young Man’s 10 L’s of Living and Dying on His Own Terms - Tarnya Hotchkin
• Glioma carers- Assessment of Individual Needs and Support  [The GAINS study]: Feasibility, preliminary effects, and Health Care Professionals perspectives of a nurse-led supportive intervention for carers of people with high-grade glioma - Diana Jones
• From Silence to Support: Embedding Sexual Wellbeing into a Nurse Led Cancer Wellness Clinic. - Natasha Keir
• “I’m here too!”: Exploring cancer survivorship experiences, needs, and preferences of people with intellectual disability and health professionals - Emma Kemp
• Effectiveness of Nurse-Led Frailty Screening in Improving Treatment Outcomes for Older Adults with Cancer: A Systematic Review - Nazib Dr Khan
• Prioritising nutrition support needs in upper gastrointestinal cancer: A co-designed Delphi approach to resource development - Amy Larsen
• Living longer, living differently: Supportive care needs of people with lung cancer and family members - Yibai YL Li
• The multimorbid cancer survivor: a case report - Lynn Lim
• Mapping the Use of Isometric Exercise for Individuals Diagnosed with Cancer: A Scoping Review - Jeffrey Lin
• Circulating cell-free DNA dynamics in endometrial cancer, health, and exercise - Eliza R Macdonald
• The effect of health behaviour interventions on alcohol consumption among people living with cancer: a systematic review - Manuela Malaguti Beaty
• Risk perception and appraisal among women at increased risk of breast cancer: a scoping review of qualitative research - Chloe CMS Maxwell-Smith
• Strategies to Optimise Outcomes in Risk Reducing Prophylactic Mastectomy and the Role of Psycho-Oncology and Behavioural Support - Chloe M Maxwell-Smith
• Who gets counted? International researchers' perspectives on barriers to engaging adolescent and young adult cancer survivors in psychosocial research - Fiona E.J. McDonald
• Structured Exercise, Physical Activity, and Fear of Cancer Recurrence Among Cancer Survivors: A Systematic Review - David Mizrahi
• Vaccinations in patients with solid organ malignancies  - Tahlia Molinaro
• Exercise engagement in adults with haematological malignancies: A qualitative systematic review - Melanie Moore
• Stronger bodies, stronger bonds: a culturally adapted wellbeing and social connectedness program for Chinese speaking cancer survivors. - James Murray
• Psychosocial guidelines and associated needs and evidence gaps - Carolyn Nickson
• Relationships between quality of life, bone pain, fatigue and disease symptoms, and physical activity, neuromuscular strength and fitness, in people with multiple myeloma - Jennifer L Nicol
• Contemporary Nutrition Care Practices and Outcomes in Patients with Head and Neck Cancer Undergoing Radiotherapy A Decade After Implementation of an Evidence-Based Model of Care - Amy OHalloran
• The acceptability of ‘RecoverEsupport’ - a digital health intervention to enhance recovery after colorectal cancer surgery: A mixed-methods evaluation within a randomised controlled trial   - Anna Palazzi-Parsons
• Pregnancy and Postpartum Associated Cancers: Translating Lived Experience into National Priorities for Earlier Diagnosis and Better Care - Rachelle Panitz
• Finding their place: Consumer leadership in cancer care - Julia Paxino
• Associations between patient satisfaction with cancer care and selected health-related quality-of-life outcomes during systemic therapy - Agnieszka Pietruszka
• Can we move beyond disease-based referral triggers and use patient-reported needs to guide earlier palliative care integration?  - Melanie Rabbets
• Surviving cancer is not enough: a low-budget case study for sector consensus and national awareness - Udani Reets
• Does adding therapist guidance to Finding My Way-Advanced improve engagement and outcomes in women with metastatic breast cancer? A feasibility pilot. - Amy Rigg
• More than a waiting space: addressing the increasing demand for support services in a cancer wellbeing centre - Phoebe Rizzoli
• A multilevel theoretical framework for distress trajectories in brain tumour populations   - Julia L Robertson
• Digital traces of psychological distress in an online brain tumour support community: a computational linguistic analysis - Julia L Robertson
• Implementing an advocacy roadmap to influence state policy: advocating for Victorian Patient Transport Assistance Scheme reform - Beth Scholes
• Financial toxicity in advanced and metastatic cancer: a qualitative scoping review of patient, caregiver and clinician perspectives. - Ashleigh R Sharman
• The financial impact of metastatic breast cancer: insights from a qualitative study in the Australian context. - Ashleigh R Sharman
• Distress trajectories and geographic inequities during radiotherapy: Analysis of nationally collected routine distress scr - Chindhu Shunmuga Sundaram
• Reducing the burden of chemotherapy-induced peripheral neuropathy (CIPN): A meta-analysis of exercise interventions - Dhiaan Sidhu
• Measuring the impact of community support groups in cancer patients and their families in a multi-cultural setting: a costing analysis  - Shivani Sivapalan
• Integrating coordinated informal care into supportive, patient-centred cancer care - Lauren Smith
• Impact of Early Integrated Palliative Care on Patient-Reported Outcomes in Patients with Lung Cancer: A Systematic Review - Aastha Srivastava
• Benchmarking Peripheral Neuropathy and Hypersensitivity Reactions in Paclitaxel-Treated Cancer Patients. - Jane J Stidworthy
• Diagnostic Performance of Current Screening Tools in Identifying Low Muscle Mass in Adults with Cancer: A Scoping Review - Natalie LX Tan
• Considerations for communicating about sexual health with culturally and linguistically diverse communities   - Alesha Thai
• Unmet supportive care needs and quality of life in people with head and neck cancer in Australia: a scoping review - Rex K.Y. Tin
• From Isolation to Connection: Consumer-Informed Online Peer Support for People Affected by Head and Neck Cancer - Simon van der Stap
• Co-designing prostate-specific patient-reported outcome measures to support person-centred adaptation of the NSW Patient Reported Measures Program - Steph Walker
• Prediction and Risk Stratification of Cancer-Related Fatigue in Radiotherapy Patients: A Prospective Cohort Study   - Na Yang
• Evaluating patient involvement in cancer multidisciplinary meetings: A systematic review - Selina Yang
• Socioeconomic Predictors & Clinical Correlates of Suicidal Ideation in Cancer Patients: A Study from LMIC - Amjad Dr. Zafar
• Oral Baclofen for Refractory Central Neuropathic Pain in a Patient with Cancer: A Case Report - Olfat Zekry
•  Symbiotic-Lung-10: a phase 2 trial of PD-1/VEGF bispecific antibody, PF-08634404, as monotherapy or in combination for non-small cell lung cancer  - Surein Arulananda
• A phase 1/2 study of mRNA-2808 in participants with relapsed or refractory multiple myeloma - Claire L Borg
• A phase 2/3 trial of a PD-1/VEGF bispecific antibody (PF-08634404) in combination with chemotherapy in first-line for extensive-stage small cell lung cancer (ES-SCLC; Symbiotic-Lung-04)  - Bryan A Chan
• Overcoming tumor penetration barriers via dual EGFR/TGF-β inhibition: A multicenter, randomized, double-blind, phase 2/3 study of ficerafusp alfa (BCA101) or placebo with pembrolizumab in first-line recurrent or metastatic (R/M) PD-L1-positive, HPV-negative head and neck squamous cell carcinoma (HNSCC): The FORTIFI-HN01 study - Marcin Dzienis
• Assessing the feasibility and tolerability of bright light therapy for the prevention of delirium in hospitalised adults with advanced cancer: protocol for a pilot RCT - LAYLA M EDWARDS
• From the Ward to the Community: An Active Approach to Childhood Cancer (The MERRIER Study) - Chrissie Ho
• Symbiotic-Lung-01: a phase 3 trial of a PD-1/VEGF bispecific antibody, PF-08634404, vs pembrolizumab in combination with platinum-based chemotherapy in first-line for locally advanced or metastatic non-small cell lung cancer - Malinda Itchins
• Bridge2Health: Building capacity to navigate the Australian cancer health care system for culturally and linguistically diverse cancer patients - Alexia Koutoulas
• Developing a nurse-led Baduanjin programme for personalized cancer survivorship care: a cross-cultural mixed-methods study of nurses’ readiness, cultural competence, and implementation needs (trial in progress) - Wei-Hsiang Lin
• Establishing the first Victorian regional CAR T-Cell therapy service and a specialised nurse project lead at Barwon Health - Leigh Matheson
• Pilot group therapy for people diagnosed with stage III melanoma – the MELGROUP study - Kelly Nunes-Zlotkowski
• Title: Trial in Progress: A mixed method cost-consequence analysis of the impacts of Decentralised Clinical Trial delivery in early phase oncology trials. - Anuradha Pala
• Evaluation of Current CIPN Screening and Management Practices: A National Survey - Susanna B Park
• Developing a Precision Supportive Care Pathway: Prospective Validation of Behavioural and Physical Function Risk Stratification During Chemotherapy (PACER Study) - Lisa E Parry
• Fit4CAR-T: Protocol for a Telehealth Exercise Prehabilitation Feasibility Study in Adults Undergoing Chimeric Antigen Receptor T-Cell Therapy for Lymphoma - Erica P Patterson
• Feasibility testing of telehealth-delivered exercise therapy for ostomates treated for cancer (FOXTROT) - Danielle J Pegg
• Symbiotic-Lung-14: a phase 2 trial of PD-1/VEGF bispecific antibody, PF-08634404, plus chemotherapy in 1L transformed small-cell lung cancer (t-SCLC)  - Rachel Roberts-Thomson
• Pilot Study Evaluating Ginger and Vitamin B6 for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderate- to High-Emetogenic Risk Regimens in an Oncology Day Unit   - Guru Sule
• Addressing information and support needs for people diagnosed with rare and less common cancers - Tamsin Farrugia